BRPI0918876A2 - composições para a profilaxia e tratamento de doença dermatológica/mucosa, e suas utilizações - Google Patents

composições para a profilaxia e tratamento de doença dermatológica/mucosa, e suas utilizações

Info

Publication number
BRPI0918876A2
BRPI0918876A2 BRPI0918876A BRPI0918876A BRPI0918876A2 BR PI0918876 A2 BRPI0918876 A2 BR PI0918876A2 BR PI0918876 A BRPI0918876 A BR PI0918876A BR PI0918876 A BRPI0918876 A BR PI0918876A BR PI0918876 A2 BRPI0918876 A2 BR PI0918876A2
Authority
BR
Brazil
Prior art keywords
dermatological
prevention
compositions
treatment
mucosal disease
Prior art date
Application number
BRPI0918876A
Other languages
English (en)
Inventor
Feleki Attila
Theodorus A C Migo
Original Assignee
Despharma Egészségügyi Szolgáltató Korlátolt Felelösségü Társaság
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Despharma Egészségügyi Szolgáltató Korlátolt Felelösségü Társaság filed Critical Despharma Egészségügyi Szolgáltató Korlátolt Felelösségü Társaság
Publication of BRPI0918876A2 publication Critical patent/BRPI0918876A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
BRPI0918876A 2008-07-28 2009-07-28 composições para a profilaxia e tratamento de doença dermatológica/mucosa, e suas utilizações BRPI0918876A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20080462004 EP2149375A1 (en) 2008-07-28 2008-07-28 Compositions for the treatment of dermatological diseases, and uses thereof
PCT/EP2009/059727 WO2010012720A1 (en) 2008-07-28 2009-07-28 Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0918876A2 true BRPI0918876A2 (pt) 2016-08-09

Family

ID=39926467

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0918876A BRPI0918876A2 (pt) 2008-07-28 2009-07-28 composições para a profilaxia e tratamento de doença dermatológica/mucosa, e suas utilizações

Country Status (16)

Country Link
US (2) US20110217358A1 (pt)
EP (2) EP2149375A1 (pt)
JP (2) JP2011529098A (pt)
KR (1) KR20110055590A (pt)
CN (1) CN102245188A (pt)
AU (1) AU2009275936B2 (pt)
BR (1) BRPI0918876A2 (pt)
CA (1) CA2732340C (pt)
EA (1) EA025440B1 (pt)
IL (1) IL210953A0 (pt)
MX (1) MX2011001138A (pt)
NZ (1) NZ591424A (pt)
SG (1) SG193155A1 (pt)
UA (1) UA106726C2 (pt)
WO (1) WO2010012720A1 (pt)
ZA (1) ZA201101517B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011825A2 (en) 2005-07-19 2007-01-25 Texas Enterosorbent, Inc. Preservative and additive for food and feed
US9597313B2 (en) 2006-06-27 2017-03-21 Timothy D. Phillips Composition and methods for the enterosorption and management of toxins
US20130101642A1 (en) * 2011-10-20 2013-04-25 Texas Enterosorbents Inc. Methods and compositions for treating oral mucositis
WO2013059827A1 (en) * 2011-10-20 2013-04-25 Salient Pharmaceuticals, Inc. Methods and compositions for treating mucositis
EP2870967A1 (de) * 2013-11-08 2015-05-13 Glock Health GmbH Behandlung entzündlicher Darmerkrankungen mit Klinoptilolith
CA2956048C (en) * 2014-07-31 2023-01-24 Amorphical Ltd. Encapsulated amorphous calcium carbonate compositions
WO2018167956A1 (ja) * 2017-03-17 2018-09-20 東洋エアゾール工業株式会社 エアゾール温感組成物及びそれを含むエアゾール製剤
US10980830B2 (en) * 2017-05-03 2021-04-20 George C. Kuefner Systems and methods for treating skin conditions with magnesium ion compositions
KR20260035292A (ko) * 2017-06-12 2026-03-12 레이크우드 아메덱스, 인크. 비스포스포신 겔 제제 및 이의 용도
CN107496445B (zh) * 2017-08-25 2020-04-28 北京海洁海斯健康科技有限公司 一种去定植药物及其制备方法与应用
WO2025232973A1 (de) * 2024-05-08 2025-11-13 Froximun Ag Klinoptilolith oder klinoptilolith enthaltendes mineralstoffgemisch zur verwendung als mineralische wundabdeckung
EP4684789A1 (en) * 2024-07-25 2026-01-28 Jakob Hraschan Micronization-activated clinoptilotite (pma-zeolite) for the treatment and prevention of oral inflammatory conditions

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0047804A1 (en) * 1980-09-15 1982-03-24 Unilever Plc Water-in-oil emulsions and process for preparing same
JPS5879927A (ja) * 1981-11-06 1983-05-13 Nippon Chem Ind Co Ltd:The 制酸剤
DE59002748D1 (de) * 1990-01-29 1993-10-21 Wogepharm Gmbh Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
JP3169621B2 (ja) * 1991-01-29 2001-05-28 株式会社タカミツ 抗菌外用剤
US5415861A (en) * 1991-07-01 1995-05-16 Avon Products, Inc. Composition and method for visibly reducing the size of skin pores
US5409903A (en) * 1992-02-18 1995-04-25 Urecap Corporation Method and compositions for the treatment of H. pylori and dermatitis
ATE246487T1 (de) * 1994-12-15 2003-08-15 Krueger Gmbh & Co Kg Badesalz mit einem gehalt von magnesiumsalzen und verfahren zur herstellung desselben
US5900258A (en) 1996-02-01 1999-05-04 Zeolitics Inc. Anti-bacterial compositions
IT1295290B1 (it) * 1997-10-07 1999-05-04 Telos S R L Composizioni cosmetiche a base di acido azelaico
RU2141311C1 (ru) * 1998-02-02 1999-11-20 Общество с ограниченной ответственностью Научно-производственный центр "Сибирская природная косметика" Косметическая очистительная маска для ухода за кожей лица "беловодье"
JP3948588B2 (ja) * 1998-03-05 2007-07-25 株式会社資生堂 皮膚バリアー機能回復促進剤
JP3503880B2 (ja) * 1998-09-25 2004-03-08 花王株式会社 口腔用組成物
CO5150202A1 (es) 1998-12-31 2002-04-29 Kimberly Clark Co Composicion de tisu facial y metodo para usarla para el secuestro de irritantes de la piel de la secrecion nasal
IL127943A (en) * 1999-01-07 2010-12-30 Shlomo Magdassi Pharmaceutical and cosmetic compositions for the treatment of skin disorders
DE60132008T2 (de) 2000-05-12 2008-12-11 Meracol Corp. Ltd., Takapuna Cetylmyristat und cetylpalmitat zur behandlung von ekzemen und/oder psoriasis
EP1409028A4 (en) * 2000-10-13 2005-07-20 On Site Gas Systems Inc BANDAGE USING MOLECULAR SIEVES
JP4728517B2 (ja) * 2001-06-29 2011-07-20 株式会社 資生堂 皮膚外用剤
JP2003012491A (ja) * 2001-07-02 2003-01-15 Shiseido Co Ltd 粉体皮膚外用剤
US8637055B2 (en) * 2002-06-24 2014-01-28 Ahava-Dead Sea Laboratories Ltd. Cosmetic compositions containing small magnetic particles
US20050058672A1 (en) * 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
US20070237834A1 (en) * 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
US20060045860A1 (en) * 2004-08-26 2006-03-02 Bioderm Research Zinc Zeolite Based Deodorants and Deodorizers
JP2006151851A (ja) * 2004-11-26 2006-06-15 Shiseido Co Ltd 乳化組成物
US7300649B2 (en) * 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
DE102005020467A1 (de) 2005-04-15 2006-10-19 Klinomed Institut für angewandte Nanotechnologie und Nanomedizin GmbH Mittel zur Therapie und Prophylaxe von Hauterkrankungen
WO2007022264A2 (en) * 2005-08-15 2007-02-22 The Regents Of The University Of California Oxides for wound healing and body repair
DE102007030198A1 (de) 2006-07-12 2008-01-24 Nano Gmbh Heilmittel

Also Published As

Publication number Publication date
IL210953A0 (en) 2011-04-28
JP2015096506A (ja) 2015-05-21
AU2009275936A8 (en) 2016-02-18
CA2732340A1 (en) 2010-02-04
CA2732340C (en) 2016-12-13
UA106726C2 (uk) 2014-10-10
SG193155A1 (en) 2013-09-30
CN102245188A (zh) 2011-11-16
US20150118314A1 (en) 2015-04-30
EP2323672A1 (en) 2011-05-25
KR20110055590A (ko) 2011-05-25
AU2009275936B2 (en) 2016-02-18
ZA201101517B (en) 2011-10-26
NZ591424A (en) 2012-11-30
EA025440B1 (ru) 2016-12-30
AU2009275936A1 (en) 2010-02-04
MX2011001138A (es) 2011-05-31
JP2011529098A (ja) 2011-12-01
WO2010012720A1 (en) 2010-02-04
US20110217358A1 (en) 2011-09-08
EA201170367A1 (ru) 2011-08-30
EP2149375A1 (en) 2010-02-03

Similar Documents

Publication Publication Date Title
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
HUS1600048I1 (hu) Készítmény Fabry-kór kezelésére
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI1006821A2 (pt) composições para o tratamento da doença de refluxo gastro-esofágico (gerd).
BR112013020809A2 (pt) composição para uso no tratamento ou prevenção de disturbio ou doença relacionada a uma mucosa
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
BRPI0917567A2 (pt) tratamento de doença respiratória
BRPI1013872A2 (pt) formulações de citrato de cálcio e lactato de cálcio para alteração de propriedades biofísicas do revestimento da mucosa
PT2894165T (pt) Métodos e composições para o tratamento de distúrbios associados ao complemento
PT2367561E (pt) Composições e métodos para o tratamento da doença celíaca
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI1008974A2 (pt) composto, composição farmacêutica, e, método para tratar, prevenir ou melhorar uma doença mediada com gsk-3
BRPI1009920A2 (pt) composições bacterianas para profilaxina e tratamento de doença degenerativa.
BRPI0913447A2 (pt) composição de éster, e, composição para cuidado pessoal.
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
BRPI0822722A2 (pt) Implemento para cuidado oral.
BRPI0906802A2 (pt) Implemento para cuidado oral.
DE602007003255D1 (de) Biegsame endoskopische Sicherheitsnadel
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
BRPI0917705A2 (pt) composto, pró-droga, composição farmacêutica, método para tratar ou prevenir uma doença ou condição, e, uso do composto
PT2641596T (pt) Utilização de derivados de 1,3-difenilprop-2-en-1-ona para tratamento de doenças hepáticas
BRPI0822572A2 (pt) Terapia guiada por imagem de doença moicardial, composição manufaturamento e aplicações
IL210953A0 (en) Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof
PT2307000E (pt) Associação de pilocarpina e metimazol para o tratamento da doença de charcot-marie-tooth e patologias relacionadas

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE EP 08462004.6 DE 28/07/2008, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O E NO ART. 28 DO ATO NORMATIVO 128/1997, POR NAO ATENDER AO DISPOSTO NO ART. 27 DO ATO NORMATIVO 128/1997, POIS NAO FOI APRESENTADA CESSAO DA REFERIDA PRIORIDADE, QUE POSSUI DEPOSITANTE DIFERENTE DO DEPOSITANTE DA FASE NACIONAL.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2472 DE 22-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.